HIV/HCV Co-Infections in Substance Abusers (R01)

The purpose of this grant is to fill gaps in our understanding of

(a) the impact of substance abuse on HIV, HIV/HCV co-infection associated disease progression,

(b) the pathogenic interactions between HIV and hepatitis C virus,

(c) hepatic and non-hepatic co-morbidities associated with HIV/HCV-co-infections in people with substance abuse disorders (SUDs),

(d) the effectiveness of interferon-free direct acting antiviral (DAAs) drug regimens to treat HIV/HCV co-infections in people with SUDs. 

Funding: No fixed limit 

Duration: 5 years 

Research Authority due date: 10 days prior to LOI

LOI (encouraged) due dates: 7.8.17, 7.12.17

Full propsal due dates: 7.9.17, 7.1.18